Example: tourism industry

毒物及び劇物取締法Q＆A - nihs.go.jp

← Back to document page

1 平成29年3月31日更新毒物及び劇物取締法Q＆A 質問一覧 1．毒物及び劇物取締法について ..... 4

Download 毒物及び劇物取締法Q＆A - nihs.go.jp

The download button is on the right, sir!

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam notification

Thank you for your participation!

Submit notification

Broken preview notification

Thank you for your participation!

Submit notification

Other abuse

Documents from same domain

NIHS 医薬品安全性情報 Vol.16 No.012018/0111/

www.nihs.go.jp

Carafate’]の製品表示が改訂され，販売名が[‘Carafate suspension’]から [‘Carafate oral suspension’]に変更さ

Carafate

Guideline for the Development of Liposome Drug …

www.nihs.go.jp

4 described in this document are also subject to other relevant notifications and guidelines. The active substances mentioned here include a low-molecular-weight chemical entity, a

Molecular, Weight

Guideline for Bioequivalence Studies of Generic …

www.nihs.go.jp

1 Guideline for Bioequivalence Studies of Generic Products for Topical Use July 7, 2003 局所皮膚適用製剤の後発医薬品のための生物学的同等性試験ガイドライン

Since 1874 遺伝子治療用製品の開発における国内 …

www.nihs.go.jp

遺伝子治療の現状海外の遺伝子治療の規制と国際調和日本の遺伝子治療と関連規制遺伝子治療指針の改正

Guideline for Bioequivalence Studies for Different ...

www.nihs.go.jp

2 Section 1: Introduction This guideline describes the principles of procedures of bioequivalence studies for oral solid dosage forms that contains a different quantity of the active ingredient from an

Guidelines, Studies, Solid, Dosage, Guideline for bioequivalence studies for, Bioequivalence, Solid dosage

Clinical Pharmacokinetic Studies of Pharmaceuticals

www.nihs.go.jp

- 1 - Clinical Pharmacokinetic Studies of Pharmaceuticals This document is an informal translation of the official text that was promulgated in Japanese on

Pharmaceutical, Clinical, Studies, Clinical pharmacokinetic studies of pharmaceuticals, Pharmacokinetic

平成 25 年度報告毒物劇物指定の ... - nihs.go.jp

www.nihs.go.jp

平成. 25 年度報告毒物劇物指定のための有害性情報の収集・評価. 物質名： n-(2-

European Medicines Agency - NIHS

www.nihs.go.jp

What is Quality Risk Management? • Proposed ICH Q9 definition: “Quality risk management is a systematic process for the identification, assessment

Management, European, Quality, Risks, Agency, Quality risk management, Medicine, European medicines agency, Nihs, Ich q9